Food Empire - Maybank Research 2024-08-14: Facing Headwinds; Downgrade To HOLD

Food Empire - Facing Headwinds; Downgrade To HOLD

Published:
Food Empire (SGX:F03) | SGinvestors.ioFood Empire (SGX:F03)
  • Food Empire (SGX:F03)'s 1H24 revenue rose 13.6% y-o-y to US$225.2m, but PATMI declined by 12.8% y-o-y to US$23.2m, less than we expected, mainly due to short-term price disruption in Russia and higher raw material prices.
  • - Read this at SGinvestors.io -

Better wait for headwinds to clear

  • Food Empire’s business model has proven resilient and we are confident in management’s execution ability. As a result, we prefer to wait for short-term headwinds to clear and downgrade Food Empire to HOLD.

Higher coffee bean prices and inventory hurt margins

  • As expected, higher coffee bean prices reduced Food Empire's 1H24 margins. Meanwhile, customers’ high inventory levels caused price disruptions across the country and there were more promotions to clear stock. As a result, Food Empire has to offer customers discounts, which may further impact margins.
  • - Read this at SGinvestors.io -

Special dividends likely to be cut

  • Read more at SGinvestors.io.




Above is the excerpt from report by Maybank Research.
Clients of Maybank Securities may be the first to access the full report in PDF @ https://www.maybanktrade.com.sg/.




Jarick Seet Maybank Research | Eric Ong Maybank Research | https://www.maybank-ke.com.sg/ 2024-08-14



Read also Maybank's most recent report:
2024-11-13 Food Empire - Revenue Growth On Track.

Previous report by Maybank:
2024-09-12 Food Empire - US$80m New Freeze-Dried Facility In Vietnam.

Price targets by other brokers at Food Empire Target Prices.

Listing of research reports at Food Empire Analyst Reports.

Relevant links:
Food Empire Share Price History,
Food Empire Announcements,
Food Empire Dividends & Corporate Actions,
Food Empire News Articles





Advertisement

You May Also Like




SGX Stock / REIT Search

Advertisement

Most Read

Trust Bank Referral Code

Advertisement